Clinical Trials Logo

Filter by:
NCT ID: NCT03250286 Recruiting - Choledocholithiasis Clinical Trials

Role of EUS in High Risk of Choledocholithiasis

Start date: July 25, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate that patients with high risk of choledocholithiasis who undergo ERCP only for patients with choledocholith in the EUS examination[EUS-ERCP group] have less negative outcomes (including false-negative results and procedure-related complications) than patients who undergo ERCP in all patients with high risk of choledocholithiasis[ERCP group]. The primary outcome is the incidence of negative outcomes (including false-negative results and procedure-related complications) in both groups. The secondary outcomes included days of hospitalization and diagnostic yield of EUS in the diagnosis of choledocholithiasis.

NCT ID: NCT03250052 Active, not recruiting - Hypertension Clinical Trials

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

Start date: July 29, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate pharmacokinetic interactions and safety between fimasartan and linagliptin in healthy male volunteers.

NCT ID: NCT03249259 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

Start date: March 10, 2016
Phase: Phase 3
Study type: Interventional

In this study, the investigators are going to investigate the efficacy of choline alfoscerate on improvement of cognitive function assessed by MMSE compared to plaebo.

NCT ID: NCT03248414 Recruiting - Obesity Clinical Trials

Investigation of Anti-obesity Properties of Lactobacillus Sakei in Obese Human Subjects

Start date: August 10, 2016
Phase: N/A
Study type: Interventional

In this study, we are going to investigate the efficacy of Lactobacillus Sakei on reduction of fat mass assessed by DEXA compared to plaebo.

NCT ID: NCT03248401 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes

Start date: September 26, 2016
Phase: Phase 4
Study type: Interventional

To investigate the effect of cilostazol compared with aspirin on carotid atherosclerosis in patients with type 2 diabetes mellitus

NCT ID: NCT03247673 Recruiting - Healthy Clinical Trials

To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin

Start date: August 7, 2017
Phase: Phase 1
Study type: Interventional

This study is a Phase 1 Randomized, Double-blind, Three-arm, Parallel Group, Single-dose Study to compare the PK, safety and immunogenicity of the proposed biosimilar test product CT-P16 with EU-approved Avastin and US-licensed Avastin after a single IV infusion of 5mg/kg of each product to healthy male subjects

NCT ID: NCT03247140 Recruiting - Clinical trials for Hypertension With Dyslipidemia

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Start date: June 10, 2017
Phase: Phase 1
Study type: Interventional

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

NCT ID: NCT03246880 Completed - Clinical trials for Benign Prostatic Hyperplasia

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Start date: September 2015
Phase: Phase 3
Study type: Interventional

A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Phase III Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients.

NCT ID: NCT03246555 Recruiting - Clinical trials for The Elderly (= 70 Years) With Essential Hypertension

Fimasartan in the Senior Subjects

FITNESS
Start date: August 7, 2017
Phase: Phase 3
Study type: Interventional

The objective of this study is to confirm the noninferiority of the blood pressure lowering effect of fimasartan and evaluate its safety compared to perindopril in the elderly with essential hypertension.

NCT ID: NCT03244319 Not yet recruiting - Clinical trials for MV(Mitral Valve) Repair

Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)

Start date: August 2017
Phase: Phase 3
Study type: Interventional

1. objectives: The primary aim of ENAVLE is to explore the efficacy of edoxaban in patients with post mitral valve repair or bioprosthetic valve implantation 2. Primary / Secondary Endpoint 1) Efficacy Endpoint Evaluation: Occurrence of thromboembolic events and any thrombus at repaired ring or bioprosthetic valves detected by follow up echocardiography or 3D CT scan 2) Safety Endpoint Evaluation - Dysfunction of treated valve caused by thrombosis on echocardiography or 3D CT scan - Major or minor bleeding described in safety outcomes